Prevalence of dyslipidemia in the Iraqi adult population

Saudi Medical Journal

Volumn 28, Issue 12, 2007, Pages 1868-1874

  Mula Abed, Waad Allah S ^a   Chilmeran, Saba K ^b  

^a ROYAL HOSPITAL   (Oman)

^b UNIVERSITY OF MOSUL   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSLIPIDEMIA; FEMALE; HUMAN; IRAQ; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; VOLUNTEER; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED;

ADULT; AGED; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; IRAQ; MALE; MIDDLE AGED; PREVALENCE; TRIGLYCERIDES;

EID: 41149174305     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Carroll K, Majeed A, Firth C, Gray J. Prevalence and management of conory heart disease in primary care: Population-based cross-sectional study using a disease register. J Public Health Med 2003; 25: 29-35.
2. Naito HK. Serum apolipoprotein measurements: An improved discriminator for assessing coronary heart disease risk. Compr Ther 1987; 13: 43-52.
3. Assmann G, Schulte H. The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension. Am J Cardiol 1987; 59: 9G-17G.
4. Goldstein JL, Brown MS. Hyperlipidemia in coronary heart disease: A biochemical genetic approach. J Lab Clin Med 1975; 85: 15-25.
5. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease. A prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999; 99: 1165-1172.
6. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH. Glycosylated low-density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient? Atherosclerosis 1993; 102: 63-67.
7. Eckel RH. Obesity and Heart Disease A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association. Circulation 1997; 96: 3248-3250.
8. Mayer-Davis EJ, D'Agostino R Jr, Karter AJ, Haffner SM, Rewers MJ, Saad M, et al. Intensity and amount of physical activity in relation to insulin sensitivity: The Insulin Resistance Atherosclerosis Study. JAMA 1998; 279: 669-674.
9. Zieske AW, Takei H, Fallon KB, Strong JP. Smoking and atherosclerosis in youth. Atherosclerosis 1999; 144: 403-408.
10. American Heart Association. Heart and stroke facts. Available from: URL: http://www.americanheart.org/presenter.jhtml?identifier=3000333.39k
11. Cullen C. Evidence that triglyceride is an indenpendent coronary heart disease risk factor. Am J Cardiol 2000; 86: 943-949.
12. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
13. Reaven GM. Syndrome X. Blood Press Suppl 1992; 4: 13-16.
14. Bloomgarden ZT. Definitions of the insulin resistance syndrome: The 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care 2004; 27: 824-830.
15. Chamsi-Pasha H. Cholesterol. How low should we go? Saudi Med J 2005; 26: 11-18.
16. National Cholesterol Education Program Expert Panel: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69.
17. National Cholesterol Education Program Expert Panel. Summary of the second report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adults Treatment Panel II). JAMA 1993; 269: 3015-3023.
18. Warnick G, Nauck M, Rifai N. Evolution of methods for measurement of HDL-cholesterol: From ultracentrifugation to homogeneous assays. Clin Chem 2001; 47: 1579-1596.
19. Recommendations of the Second Joint Task Force and other societies on coronary prevention. Eur Heart J 1998; 19: 1434-1503.
20. Wood D, Durrington P, Poulter N. Joint British recommendations on the prevention of coronary heart disease in clinical practice. Heart 1998; 80: S1-S29.
21. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase coupled method for the colormetric determination of serum triglycerides. Clin Chem 1983; 29: 538-542.
22. Slickers KA. Enzyme linked assays for cholesterol. CRC Crit Rev Clin Lab Sci 1977; 8: 193-212.
23. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoprotein separated by three different methods. Clin Chem 1977; 23: 882-884.
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 449-502.
25. Hill SAB, editor. A short textbook of medical statistics. 11th ed. London (UK), Hodder and Stoughton; 1984. p. 201-202.
26. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95: 1-4.
27. Rizzo M, Berneis K, Corrado E, Novo S. The significance of low-density-lipoproteins size in vascular diseases. Int Angiol 2006; 25: 4-9.
28. Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol 2006; 97: 1007-1009.
29. Levinson SS. Comparison of apolipoprotein B and non-high-density lipoprotein cholesterol for identifying coronary artery disease risk based on receiver operating curve analysis. Am J Clin Pathol 2007; 127: 449-455.
30. [No authors listed]. Current status of blood cholesterol measurement in clinical laboratories in the United States: A report from the Laboratory Standardization Panel of the National Cholesterol Education Program. Clin Chem 1988; 34: 193-201.
31. Unwin N, Thomson R, O'Bryne AM, Laker M, Armstrong H. Implications of applying widely accepted cholesterol screening and management guidelines to a British adult population: Cross sectional study of cardiovascular disease and risk factors. BMJ 1998; 317: 1125-1130.
32. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720-732.
33. Laker MF; Joint British Societies. Cardiovascular disease prevention: the new joint British Societie's guidelines. Ann Clin Biochem 2006; 43: 335-339.
34. AbalKhail BA, Shawky S, Ghabrah TM, Milaat WA. Hypercholesterolemia and 5-year risk of development of coronary heart disease among university and school workers in Jeddah, Saudi Arabia. Prev Med 2000; 31: 390-395.
35. Al-Shehri SN, Saleh ZA, Salama MM, Hassan YM. Prevalence of hyperlipidemia among Saudi school children in Riyadh. Ann Saudi Med 2004; 24: 6-8.
36. Batieha A, Jaddou HY, Ajlouni KM. Hyperlipidemia in Jordan: A community-based study. Saudi Med J 1997; 18: 279-384.
37. Fernando DJS, Sinibaddana SH, Desilva DR, Perera SD. The prevalence of obesity and other coronary risk factors in suburban Sri Lanka community. Asia Pac J Clin Nutr 1994; 3: 155-159.
38. Hoerger TJ, Bala MV, Bray JW, Wilcosky TC, LaRosa J. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am J Cardiol 1998; 82: 61-65.